274 related articles for article (PubMed ID: 16718515)
1. Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy.
Carlsson J; Eriksson V; Stenerlöw B; Lundqvist H
Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1185-95. PubMed ID: 16718515
[TBL] [Abstract][Full Text] [Related]
2. Effects of radiation on growth of two human tumour cell lines surviving a previous high dose, low dose-rate, radionuclide exposure.
Segerström L; Stenerlow B; Eriksson V; Carlsson J
Int J Oncol; 2008 Aug; 33(2):341-9. PubMed ID: 18636155
[TBL] [Abstract][Full Text] [Related]
3. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides.
Boyd M; Ross SC; Dorrens J; Fullerton NE; Tan KW; Zalutsky MR; Mairs RJ
J Nucl Med; 2006 Jun; 47(6):1007-15. PubMed ID: 16741311
[TBL] [Abstract][Full Text] [Related]
4. Response of chronic hypoxic cells to low dose-rate irradiation.
Pettersen EO; Bjørhovde I; Søvik A; Edin NF; Zachar V; Hole EO; Sandvik JA; Ebbesen P
Int J Radiat Biol; 2007 May; 83(5):331-45. PubMed ID: 17457758
[TBL] [Abstract][Full Text] [Related]
5. Study on cell survival, induction of apoptosis and micronucleus formation in SCL-II cells after exposure to the auger electron emitter (99m)Tc.
Kriehuber R; Kadenbach K; Schultz F; Weiss DG
Int J Radiat Biol; 2004; 80(11-12):875-80. PubMed ID: 15764396
[TBL] [Abstract][Full Text] [Related]
6. Effect of subsequent acute-dose irradiation on cell survival in vitro following low dose-rate exposures.
Mitchell CR; Joiner MC
Int J Radiat Biol; 2002 Nov; 78(11):981-90. PubMed ID: 12456285
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells.
Nayak TK; Norenberg JP; Anderson TL; Prossnitz ER; Stabin MG; Atcher RW
Nucl Med Biol; 2007 Feb; 34(2):185-93. PubMed ID: 17307126
[TBL] [Abstract][Full Text] [Related]
8. Overview of radiosensitivity of human tumor cells to low-dose-rate irradiation.
Williams JR; Zhang Y; Zhou H; Gridley DS; Koch CJ; Slater JM; Little JB
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):909-17. PubMed ID: 19014780
[TBL] [Abstract][Full Text] [Related]
9. Changes in tumor cell response due to prolonged dose delivery times in fractionated radiation therapy.
Paganetti H
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):892-900. PubMed ID: 16199319
[TBL] [Abstract][Full Text] [Related]
10. Dose rate dependence of the relative biological effectiveness of 103Pd for continuous low dose rate irradiation of BA1112 rhabdomyosarcoma cells in vitro relative to acute exposures.
Nath R; Bongiorni P; Chen Z; Gragnano J; Rockwell S
Int J Radiat Biol; 2005 Sep; 81(9):689-99. PubMed ID: 16368647
[TBL] [Abstract][Full Text] [Related]
11. Tumor control probability for tumor therapy with beta radionuclide interstitial injection.
Chen Y; Geng J; Tian J; He Y; Chen S
Biomed Mater Eng; 2004; 14(3):333-5. PubMed ID: 15299245
[No Abstract] [Full Text] [Related]
12. Single-hit mechanism of tumour cell killing by radiation.
Chapman JD
Int J Radiat Biol; 2003 Feb; 79(2):71-81. PubMed ID: 12569011
[TBL] [Abstract][Full Text] [Related]
13. Bystander effects induced by continuous low-dose-rate 125I seeds potentiate the killing action of irradiation on human lung cancer cells in vitro.
Chen HH; Jia RF; Yu L; Zhao MJ; Shao CL; Cheng WY
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1560-6. PubMed ID: 19028278
[TBL] [Abstract][Full Text] [Related]
14. Radiation quality-dependent bystander effects elicited by targeted radionuclides.
Boyd M; Sorensen A; McCluskey AG; Mairs RJ
J Pharm Pharmacol; 2008 Aug; 60(8):951-8. PubMed ID: 18644188
[TBL] [Abstract][Full Text] [Related]
15. MIRD continuing education: Bystander and low dose-rate effects: are these relevant to radionuclide therapy?
Sgouros G; Knox SJ; Joiner MC; Morgan WF; Kassis AI
J Nucl Med; 2007 Oct; 48(10):1683-91. PubMed ID: 17873139
[TBL] [Abstract][Full Text] [Related]
16. Combined effect of tumor necrosis factor-alpha and ionizing radiation on the induction of apoptosis in 5637 bladder carcinoma cells.
Baierlein SA; Distel L; Sieber R; Weiss C; Rödel C; Sauer R; Rödel F
Strahlenther Onkol; 2006 Aug; 182(8):467-72. PubMed ID: 16896593
[TBL] [Abstract][Full Text] [Related]
17. Effects of very low dose-rate (90)Sr/(90)Y exposure on the acute moist desquamation response of pig skin.
Millar WT; Hopewell JW
Radiother Oncol; 2007 May; 83(2):187-95. PubMed ID: 17467835
[TBL] [Abstract][Full Text] [Related]
18. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
[TBL] [Abstract][Full Text] [Related]
19. Comparable cell survival between high dose rate flattening filter free and conventional dose rate irradiation.
Verbakel WF; van den Berg J; Slotman BJ; Sminia P
Acta Oncol; 2013 Apr; 52(3):652-7. PubMed ID: 23126524
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.
Monazzam A; Razifar P; Ide S; Rugaard Jensen M; Josephsson R; Blomqvist C; Langström B; Bergström M
Nucl Med Biol; 2009 Apr; 36(3):335-42. PubMed ID: 19324279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
